A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma

An article created on 2026-10-20 15:35:46

#	Наименование новости	Информативность	Дата публикации
1	Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathway	29.05	20-10-2026
2	Cross-Platform Evaluation of a Locked Two-Pathway Transcriptomic Score for Early Mortality in Diffuse Large B-Cell Lymphoma	28.18	19-10-2026
3	ABCB1-Mediated Drug Efflux Drives Resistance to VpreB1-Targeted Antibody-Drug Conjugates in B-cell Lymphoblastic Leukemia	36.32	21-10-2026
4	A prospective study of cardiac biomarkers in monitoring cardiac arrhythmia in Non-Hodgkin's lymphoma chemotherapy	17.1	20-10-2026
5	Intratumoral influenza A virus infection drives platinum resistance and invasive reprogramming in NSCLC	15.26	21-10-2026
6	High-throughput screening identifies proteasome inhibition as promising strategy for treatment of ALK-mutant neuroblastoma	25.79	19-10-2026
7	Illuminating Innate-Like T-Cell Signaling: From Signaling Architecture to Rational Cancer Immunotherapy	25.47	21-10-2026
8	Lineage plasticity and tumor microenvironment transcriptional features define a novel aggressive state in pediatric rhabdomyosarcoma	14.76	20-10-2026
9	Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC	28.75	20-08-2026
10	Targeting the p53–TFAM Axis to Overcome Exercise Intolerance in Long COVID	15.88	20-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.31. Источник: www.researchsquare.com.

Найдите то, что Вас интересует